In this section

Combining iron supplements with SGLT2 inhibitor-stimulated erythropoiesis in heart failure: should we be worried about thromboembolic events?

Packer, M. and Cleland, J. G.F. (2023) Combining iron supplements with SGLT2 inhibitor-stimulated erythropoiesis in heart failure: should we be worried about thromboembolic events? Journal of Cardiac Failure, 29(3), pp. 403-406. (doi: 10.1016/j.cardfail.2022.12.007) (PMID:36563739)

[img] Text
289129.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.
328kB

Abstract

No abstract available.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Cleland, Professor John
Authors: Packer, M., and Cleland, J. G.F.
College/School:College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
Journal Name:Journal of Cardiac Failure
Publisher:Elsevier
ISSN:1071-9164
ISSN (Online):1532-8414
Published Online:21 December 2022
Copyright Holders:Copyright © 2022 The Authors
First Published:First published in Journal of Cardiac Failure 29(3): 403-406
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record

Funder and Project Information
Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
303944BHF Centre of ExcellenceColin BerryBritish Heart Foundation (BHF)RE/18/6/34217CAMS - Cardiovascular Science
Deposit and Record Details